Historical record - last NADAC effective date: 2/21/2024
Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.3159 per EA under NDC 57664064708. Its NADAC has been published 507 times since Jun 11, 2014.
FDA first approved this application on Sep 9, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 30 MG TAB
Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664064708
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040480FDA Approved
9/9/2003
TE Code
AB
On Market Since
9/9/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 507 times since Jun 11, 2014, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3159 per EA |
|---|---|
| All-time high | $0.9334 (Jun 11, 2014) |
| All-time low | $0.2807 (Jul 20, 2022) |
| Median price | $0.4779 |
| Average price | $0.5070 |
| Largest weekly change | +20.6% (Dec 23, 2015) |
| Weeks tracked | 507 |
| Tracking since | Jun 11, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-11.9%
5Y
-13.8%
All
-66.2%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.3159 per EA (NDC 57664064708), effective Feb 21, 2024.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 66.2%. It has been tracked across 507 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Jun 11, 2014, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2807 (Jul 20, 2022) to a high of $0.9334 (Jun 11, 2014), with a median of $0.4779 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHETAMIN 30 MG TAB, is $0.3031 per EA — about 4% below DEXTROAMP-AMPHETAMIN 30 MG TAB.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 57664064708) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.